Google DeepMind·· 2026-05-16
Accelerating discovery of liver disease mechanisms
Accelerating discovery of liver disease mechanisms
AI summary
A University of Edinburgh team used Google Co-Scientist to study MASH liver disease, integrating liver biology and pharmacology evidence to identify the NLRP3 inflammasome as a key molecular bridge between inflammation and metabolism. This explains why resmetirom works for only a minority of eligible patients. The experimentally validated hypothesis could advance targeted dual therapies.
Selection record
Threshold 60Official, first-handFirst 38Second 42
Not admittedSum of both 80 < twice the threshold 120
- Source tier
- Official, first-hand; this tier's threshold is 60
- Pre-filter
- passed：用Co-Scientist AI系统生成肝病新假设
A model scores each item twice, independently, against one written standard, out of 100. An item is admitted only when the two scores add up to twice the threshold. The threshold is set per source tier.
Source: Google DeepMind · deepmind.google